|
HY-103466-1mg
|
MedChemexpress LLC
|
FM4-64 [CAS 162112-35-8]
|
|
|
|
|
HY-103466-5mg
|
MedChemexpress LLC
|
FM4-64 [CAS 162112-35-8]
|
|
|
|
|
HY-112688-10mg
|
MedChemexpress LLC
|
H-Arg-4MBetaNA [CAS 60285-94-1]
|
|
|
|
|
HY-112688-25mg
|
MedChemexpress LLC
|
H-Arg-4MBetaNA [CAS 60285-94-1]
|
|
|
|
|
HY-112688-5mg
|
MedChemexpress LLC
|
H-Arg-4MBetaNA [CAS 60285-94-1]
|
|
|
|
|
HY-112688-50mg
|
MedChemexpress LLC
|
H-Arg-4MBetaNA [CAS 60285-94-1]
|
|
|
|
|
HY-113133-1mg
|
MedChemexpress LLC
|
Kojibiose [CAS 2140-29-6]
|
|
|
|
|
HY-113133-10mg
|
MedChemexpress LLC
|
Kojibiose [CAS 2140-29-6]
|
|
|
|
|
HY-113133-100mg
|
MedChemexpress LLC
|
Kojibiose [CAS 2140-29-6]
|
|
|
|
|
HY-113133-25mg
|
MedChemexpress LLC
|
Kojibiose [CAS 2140-29-6]
|
|
|
|
|
HY-113133-5mg
|
MedChemexpress LLC
|
Kojibiose [CAS 2140-29-6]
|
|
|
|
|
HY-113133-50mg
|
MedChemexpress LLC
|
Kojibiose [CAS 2140-29-6]
|
|
|
|
|
HY-113303-10mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
|
HY-113303-100mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
|
HY-113303-25mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
|
HY-113303-5mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
|
HY-113303-50mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
|
HY-131688-1mg
|
MedChemexpress LLC
|
2-Chlorohexadecanoic acid [CAS 19117-92-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-132142-10mg
|
MedChemexpress LLC
|
5-Propargylamino-dCTP [CAS 115899-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-132142-5mg
|
MedChemexpress LLC
|
5-Propargylamino-dCTP [CAS 115899-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-137843-10mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-137843-100mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-137843-25mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-137843-5mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-137843-50mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
